What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?
How do Courts address inventiveness of a second medical use patent in light of the first medical use? Also, what issues arise with disclosure of clinical trial protocols?
On January 26, join members of Gowling WLG's global intellectual property team for a live webinar to get answers to these questions and more. We will look at the validity of second medical use patents across the UK, Canada, Russia and China, and help you understand what to expect when the validity of a second medical use patent is called into question.
Have questions that you would like us to address during the live webinar? Please submit them here by January 19 as they will help to direct the discussion during the live webinar. Our presenters will answer as many submitted questions as possible.
*This program is eligible for up to 1 hour of CPD credits with the LSO and LSBC, and may be eligible for up to 1 hour of CPD/CLE credits in other jurisdictions. If you indicate that a certificate is required on your registration form, we will email you your certificate after the session.
Event is in progress